search
Back to results

Ability of Four Toothpastes to Remove Plaque

Primary Purpose

Dental Plaque

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
67% Sodium Bicarbonate with 6 herbs plus 923parts per million (ppm) Sodium Fluoride
67% Sodium Bicarbonate without herbs plus 923 ppm Sodium Fluoride
62% Sodium Bicarbonate with 6 herbs and 5% w/w silica plus 923 ppm Sodium
0% Sodium Bicarbonate without herbs plus 923ppm Sodium Fluoride
Sponsored by
GlaxoSmithKline
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dental Plaque

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
  • Aged at least 18 years
  • Understands and is willing, able and likely to comply with all study procedures and restrictions
  • Good general health with (in the opinion of the Investigator) no clinically significant and relevant abnormalities of medical history or dental history.
  • Good dental health based on medical history and oral soft tissue examination at screening
  • At least 20 gradable, natural, uncrowned teeth with both facial and lingual scoreable surfaces (gradable teeth are those where restorative materials cover less than 25% of the tooth surface graded)
  • Plaque Score: Mean Turesky plaque score of ≥ 2.00 at treatment visit 1 pre-brushing plaque assessment

Exclusion Criteria:

  • Women who are known to be pregnant or who are intending to become pregnant over the duration of the study
  • Women who are breast-feeding
  • Antibiotic treatment within 14 days prior to Treatment Visit 1 or throughout the study
  • Any other treatment that would interfere with the study results/conduct, at the discretion of the examiner or investigator
  • Diabetes mellitus type I or II
  • Any disease systemic or localized, dental or non dental, which could put the participant's health at risk or interfere with the study results/conduct, at the discretion of the examiner or investigator
  • High levels of extrinsic stain or calculus deposits which might interfere with plaque assessments
  • Dental condition/ disease requiring immediate treatment
  • Pre-existing sensitivity to oral care products
  • Severe gingivitis
  • Periodontitis with pocket depth > 5mm affecting more than two teeth
  • Moderate or severe recession
  • Presence of orthodontic bands or appliances, extensive crowns, partial dentures, or fixed retainers on the maxillary or mandibular teeth
  • Obvious active carious lesions needing immediate care
  • Intra-oral decorative tattoos, or tongue and or lip piercing
  • Oral lesions/manifestations that would impact on the outcome of the study
  • Presence of oral or peri-oral ulceration including herpetic lesions at the time of screening or at baseline
  • Known or suspected intolerance or hypersensitivity to the studymaterials (or closely related compounds) or any of their stated ingredients
  • Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit
  • Previous participation in this study
  • Recent history (within the last year) of alcohol or other substance abuse
  • Current use of Listerine or any antimicrobial mouth rinse containing Chlorhexidine or Cetrylpyridinium Chloride (CPC)
  • Participant unwilling to abstain from using chewing tobacco (with or without tobacco)
  • Participant unwilling to abstain from smoking on the morning prior to treatment visits
  • An employee of the sponsor or the study site or members of their immediate family

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm 4

    Arm Type

    Experimental

    Experimental

    Experimental

    Experimental

    Arm Label

    Test product 1

    Test product 2

    Test product 3

    Test product 4

    Arm Description

    Participants will brush once (1.5g ± 0.05g of Test product 1), under supervision of study staff for one timed minute

    Participants will brush once (1.5g ± 0.05g of Test product 2), under supervision of study staff for one timed minute

    Participants will brush once (1.5g ± 0.05g of Test product 3), under supervision of study staff for one timed minute

    Participants will brush once (1.5g ± 0.05g of Test product 4), under supervision of study staff for one timed minute

    Outcomes

    Primary Outcome Measures

    Mean Change From Baseline (Pre-brushing to Post-brushing) in Turesky Score After Single Supervised Use (Test Product 1 Versus [vs] Test Product 4) After 4 Weeks
    The dental examiner used Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth.Overall plaque scores were calculated taking average over all tooth sites for participant.Plaque was first disclosed using dye solution followed by disclosing solution.They expectorated and rinsed with 10 milliliters (mL) water for 10 seconds (sec),expectorated again. Plaque was assessed with each tooth being divided into 6 areas including mesiofacial,facial,distofacial,mesiolingual,lingual,distolingual surfaces.Disclosed plaque was scored for each tooth surface separately as:0 No plaque;1 Slight flecks of plaque at cervical margin of the tooth;2 A thin continuous band of plaque(1 mm or smaller) at cervical margin of tooth;3 A band of plaque wider than 1 mm but covering less than 1/3 of the crown of tooth;4 Plaque covering at least 1/3 but less than 2/3 of crown of tooth;5 Plaque covering 2/3 or more of crown of tooth.Score range 0-5.Lower scores indicate less plaque area.

    Secondary Outcome Measures

    Mean Change From Baseline (Pre-brushing to Post Brushing) in Turesky Score After Single Supervised Use for Test Products 1, 2, 3 and 4 After 4 Weeks
    The dental examiner used Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth.Overall plaque scores were calculated taking average over all tooth sites for participant.Plaque was first disclosed using dye solution followed by disclosing solution.They expectorated and rinsed with 10 mL of water for 10 sec,expectorated again. Plaque was assessed with each tooth being divided into 6 areas including mesiofacial,facial,distofacial,mesiolingual,lingual,distolingual surfaces.Disclosed plaque was scored for each tooth surface separately as:0 No plaque;1 Slight flecks of plaque at cervical margin of the tooth;2 A thin continuous band of plaque(1 mm or smaller) at cervical margin of tooth;3 A band of plaque wider than 1 mm but covering less than 1/3 of the crown of tooth;4 Plaque covering at least 1/3 but less than 2/3 of crown of tooth;5 Plaque covering 2/3 or more of crown of tooth.Score range 0-5.Lower scores indicate less plaque area.

    Full Information

    First Posted
    September 12, 2017
    Last Updated
    October 15, 2018
    Sponsor
    GlaxoSmithKline
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03285984
    Brief Title
    Ability of Four Toothpastes to Remove Plaque
    Official Title
    Plaque Removal Efficacy of Four Dentifrices in a Single Brushing Model
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2018
    Overall Recruitment Status
    Completed
    Study Start Date
    March 27, 2012 (Actual)
    Primary Completion Date
    May 8, 2012 (Actual)
    Study Completion Date
    May 8, 2012 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    GlaxoSmithKline

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The aim of this study is to evaluate and compare the plaque removal efficacy of four experimental toothpastes following a single timed brushing. Prior to each treatment visit, participants will abstain from oral hygiene for a period of 24 hours (+6hrs, -2hrs), immediately preceding a pre-brushing dental plaque evaluation. Participants will then brush once under supervision for one timed minute with each dentifrice after which re-disclosing and a post-brushing plaque assessment will be carried out.
    Detailed Description
    This study will be a single centre, randomized, controlled, examiner blind, four treatment, four period crossover design. At the screening visit, following provision of written informed consent, eligible participants will be provided with a washout toothpaste and toothbrush for use at home during the study and for at least 14 days prior to the first treatment visit. Participants will then be scheduled to attend the first of four treatment visits a minimum of 14 days later. For each treatment visit, participants must abstain from oral hygiene for a period of 24 hours (+6hrs, -2hrs), immediately preceding the pre-brushing dental plaque evaluation. All the participants will undergo an oral soft tissue (OST) examination followed by disclosing and a dental plaque assessment. At the treatment visit 1 pre-brushing plaque assessment, those who develop a sufficient amount of plaque (Turesky mean score ≥ 2.00) will be randomized to study treatment. Participants will then brush once (1.5 grams [g] ± 0.05g of assigned toothpaste), under supervision of study staff for one timed minute, with one of the four test toothpastes after which re-disclosing and a post-brushing plaque assessment will be carried out. Participants will be allowed to brush with the washout paste following the post assessment plaque assessments. A minimum of three days washout period will follow each treatment period during which period Participants will brush with a commercial washout toothpaste. Participants will complete four treatment visits and will brush once with each of the four test toothpastes throughout the course of the study.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Dental Plaque

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Model Description
    The randomization schedule will indicate the treatment order sequence. Each subject will complete all four treatment regimens, one treatment regimen in each of the four treatment periods. This randomization will use a Williams Square layout and be provided by the Biostatistics Department, GSKCH.
    Masking
    InvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    56 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Test product 1
    Arm Type
    Experimental
    Arm Description
    Participants will brush once (1.5g ± 0.05g of Test product 1), under supervision of study staff for one timed minute
    Arm Title
    Test product 2
    Arm Type
    Experimental
    Arm Description
    Participants will brush once (1.5g ± 0.05g of Test product 2), under supervision of study staff for one timed minute
    Arm Title
    Test product 3
    Arm Type
    Experimental
    Arm Description
    Participants will brush once (1.5g ± 0.05g of Test product 3), under supervision of study staff for one timed minute
    Arm Title
    Test product 4
    Arm Type
    Experimental
    Arm Description
    Participants will brush once (1.5g ± 0.05g of Test product 4), under supervision of study staff for one timed minute
    Intervention Type
    Other
    Intervention Name(s)
    67% Sodium Bicarbonate with 6 herbs plus 923parts per million (ppm) Sodium Fluoride
    Intervention Description
    Toothpaste containing 67 percent (%) Sodium Bicarbonate with 6 herbs plus 923parts per million (ppm) Sodium Fluoride
    Intervention Type
    Other
    Intervention Name(s)
    67% Sodium Bicarbonate without herbs plus 923 ppm Sodium Fluoride
    Intervention Description
    Toothpaste containing 67% Sodium Bicarbonate without herbs plus 923 ppm Sodium Fluoride
    Intervention Type
    Other
    Intervention Name(s)
    62% Sodium Bicarbonate with 6 herbs and 5% w/w silica plus 923 ppm Sodium
    Intervention Description
    Whitening Toothpaste containing 62% Sodium Bicarbonate with 6 herbs and 5% w/w silica plus 923 ppm Sodium
    Intervention Type
    Other
    Intervention Name(s)
    0% Sodium Bicarbonate without herbs plus 923ppm Sodium Fluoride
    Intervention Description
    Toothpaste containing 0% Sodium Bicarbonate without herbs plus 923ppm Sodium Fluoride
    Primary Outcome Measure Information:
    Title
    Mean Change From Baseline (Pre-brushing to Post-brushing) in Turesky Score After Single Supervised Use (Test Product 1 Versus [vs] Test Product 4) After 4 Weeks
    Description
    The dental examiner used Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth.Overall plaque scores were calculated taking average over all tooth sites for participant.Plaque was first disclosed using dye solution followed by disclosing solution.They expectorated and rinsed with 10 milliliters (mL) water for 10 seconds (sec),expectorated again. Plaque was assessed with each tooth being divided into 6 areas including mesiofacial,facial,distofacial,mesiolingual,lingual,distolingual surfaces.Disclosed plaque was scored for each tooth surface separately as:0 No plaque;1 Slight flecks of plaque at cervical margin of the tooth;2 A thin continuous band of plaque(1 mm or smaller) at cervical margin of tooth;3 A band of plaque wider than 1 mm but covering less than 1/3 of the crown of tooth;4 Plaque covering at least 1/3 but less than 2/3 of crown of tooth;5 Plaque covering 2/3 or more of crown of tooth.Score range 0-5.Lower scores indicate less plaque area.
    Time Frame
    Baseline to 4 Weeks
    Secondary Outcome Measure Information:
    Title
    Mean Change From Baseline (Pre-brushing to Post Brushing) in Turesky Score After Single Supervised Use for Test Products 1, 2, 3 and 4 After 4 Weeks
    Description
    The dental examiner used Turesky Modification of the Quigley Hein Index to assess plaque on all gradable teeth.Overall plaque scores were calculated taking average over all tooth sites for participant.Plaque was first disclosed using dye solution followed by disclosing solution.They expectorated and rinsed with 10 mL of water for 10 sec,expectorated again. Plaque was assessed with each tooth being divided into 6 areas including mesiofacial,facial,distofacial,mesiolingual,lingual,distolingual surfaces.Disclosed plaque was scored for each tooth surface separately as:0 No plaque;1 Slight flecks of plaque at cervical margin of the tooth;2 A thin continuous band of plaque(1 mm or smaller) at cervical margin of tooth;3 A band of plaque wider than 1 mm but covering less than 1/3 of the crown of tooth;4 Plaque covering at least 1/3 but less than 2/3 of crown of tooth;5 Plaque covering 2/3 or more of crown of tooth.Score range 0-5.Lower scores indicate less plaque area.
    Time Frame
    Baseline to 4 Weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form. Aged at least 18 years Understands and is willing, able and likely to comply with all study procedures and restrictions Good general health with (in the opinion of the Investigator) no clinically significant and relevant abnormalities of medical history or dental history. Good dental health based on medical history and oral soft tissue examination at screening At least 20 gradable, natural, uncrowned teeth with both facial and lingual scoreable surfaces (gradable teeth are those where restorative materials cover less than 25% of the tooth surface graded) Plaque Score: Mean Turesky plaque score of ≥ 2.00 at treatment visit 1 pre-brushing plaque assessment Exclusion Criteria: Women who are known to be pregnant or who are intending to become pregnant over the duration of the study Women who are breast-feeding Antibiotic treatment within 14 days prior to Treatment Visit 1 or throughout the study Any other treatment that would interfere with the study results/conduct, at the discretion of the examiner or investigator Diabetes mellitus type I or II Any disease systemic or localized, dental or non dental, which could put the participant's health at risk or interfere with the study results/conduct, at the discretion of the examiner or investigator High levels of extrinsic stain or calculus deposits which might interfere with plaque assessments Dental condition/ disease requiring immediate treatment Pre-existing sensitivity to oral care products Severe gingivitis Periodontitis with pocket depth > 5mm affecting more than two teeth Moderate or severe recession Presence of orthodontic bands or appliances, extensive crowns, partial dentures, or fixed retainers on the maxillary or mandibular teeth Obvious active carious lesions needing immediate care Intra-oral decorative tattoos, or tongue and or lip piercing Oral lesions/manifestations that would impact on the outcome of the study Presence of oral or peri-oral ulceration including herpetic lesions at the time of screening or at baseline Known or suspected intolerance or hypersensitivity to the studymaterials (or closely related compounds) or any of their stated ingredients Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit Previous participation in this study Recent history (within the last year) of alcohol or other substance abuse Current use of Listerine or any antimicrobial mouth rinse containing Chlorhexidine or Cetrylpyridinium Chloride (CPC) Participant unwilling to abstain from using chewing tobacco (with or without tobacco) Participant unwilling to abstain from smoking on the morning prior to treatment visits An employee of the sponsor or the study site or members of their immediate family
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    GSK Clinical Trials
    Organizational Affiliation
    GlaxoSmithKline
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    29971158
    Citation
    Bosma ML, Milleman KR, Akwagyiram I, Targett D, Milleman JL. A randomised controlled trial to evaluate the plaque removal efficacy of sodium bicarbonate dentifrices in a single brushing clinical model. BDJ Open. 2018 Jun 4;4:17037. doi: 10.1038/s41405-018-0003-7. eCollection 2018.
    Results Reference
    derived

    Learn more about this trial

    Ability of Four Toothpastes to Remove Plaque

    We'll reach out to this number within 24 hrs